Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology
- ByInvesting.com-
Adaptive Biotechnologies (NASDAQ:ADPT) Corporation (Nasdaq: ADPT) today announced that the U.S. Food and Drug Administration has accepted an investigational new drug (IND)...